<ARTICLE> 6
<CIK> 0000886244
<NAME> THE BRINSON FUNDS

   <NUMBER> 142
   <NAME> BRINSON GLOBAL BIOTECH - CLASS N
<MULTIPLIER> 1

                             
<PERIOD-TYPE>                  OTHER
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               JUN-30-2000
<INVESTMENTS-AT-COST>                          638,088
<INVESTMENTS-AT-VALUE>                         738,295
<RECEIVABLES>                                  123,110
<ASSETS-OTHER>                                       0
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                                 861,405
<PAYABLE-FOR-SECURITIES>                        10,188
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                       10,779
<TOTAL-LIABILITIES>                             20,967
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                       732,490
<SHARES-COMMON-STOCK>                           57,263
<SHARES-COMMON-PRIOR>                                0
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                          7,741
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                       100,207
<NET-ASSETS>                                   840,438
<DIVIDEND-INCOME>                                    0
<INTEREST-INCOME>                                  317
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                     552
<NET-INVESTMENT-INCOME>                          (235)
<REALIZED-GAINS-CURRENT>                         7,976
<APPREC-INCREASE-CURRENT>                      100,207
<NET-CHANGE-FROM-OPS>                          107,948
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                            0
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                              0
<NUMBER-OF-SHARES-REDEEMED>                          0
<SHARES-REINVESTED>                                  0
<NET-CHANGE-IN-ASSETS>                         340,428
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                            0
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                              480
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                  4,289
<AVERAGE-NET-ASSETS>                           534,437
<PER-SHARE-NAV-BEGIN>                            10.00
<PER-SHARE-NII>                                 (0.01)
<PER-SHARE-GAIN-APPREC>                           2.08
<PER-SHARE-DIVIDEND>                                 0
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              12.07
<EXPENSE-RATIO>                                   1.55